KR100921172B1 - 식이섬유를 함유하는 슬리밍 식품 조성물 - Google Patents
식이섬유를 함유하는 슬리밍 식품 조성물 Download PDFInfo
- Publication number
- KR100921172B1 KR100921172B1 KR1020030095414A KR20030095414A KR100921172B1 KR 100921172 B1 KR100921172 B1 KR 100921172B1 KR 1020030095414 A KR1020030095414 A KR 1020030095414A KR 20030095414 A KR20030095414 A KR 20030095414A KR 100921172 B1 KR100921172 B1 KR 100921172B1
- Authority
- KR
- South Korea
- Prior art keywords
- slimming
- dietary fiber
- deanine
- green tea
- obesity
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 33
- 235000013305 food Nutrition 0.000 title claims abstract description 27
- 235000013325 dietary fiber Nutrition 0.000 title abstract description 24
- 208000008589 Obesity Diseases 0.000 title abstract description 16
- 235000020824 obesity Nutrition 0.000 title abstract description 16
- 238000011282 treatment Methods 0.000 title description 3
- ZMJBYMUCKBYSCP-UHFFFAOYSA-N Hydroxycitric acid Chemical compound OC(=O)C(O)C(O)(C(O)=O)CC(O)=O ZMJBYMUCKBYSCP-UHFFFAOYSA-N 0.000 claims abstract description 31
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 28
- 244000269722 Thea sinensis Species 0.000 claims abstract description 22
- 235000009569 green tea Nutrition 0.000 claims abstract description 22
- 229920002774 Maltodextrin Polymers 0.000 claims abstract description 9
- 239000005913 Maltodextrin Substances 0.000 claims abstract description 9
- 229940035034 maltodextrin Drugs 0.000 claims abstract description 9
- 238000009472 formulation Methods 0.000 claims description 8
- 239000008187 granular material Substances 0.000 claims description 5
- 235000013736 caramel Nutrition 0.000 claims description 4
- MIDXCONKKJTLDX-UHFFFAOYSA-N 3,5-dimethylcyclopentane-1,2-dione Chemical compound CC1CC(C)C(=O)C1=O MIDXCONKKJTLDX-UHFFFAOYSA-N 0.000 claims description 3
- 239000002775 capsule Substances 0.000 claims description 2
- 239000003826 tablet Substances 0.000 claims description 2
- 235000010469 Glycine max Nutrition 0.000 abstract description 28
- 210000000577 adipose tissue Anatomy 0.000 abstract description 21
- 244000068988 Glycine max Species 0.000 abstract description 20
- 230000000694 effects Effects 0.000 abstract description 18
- 231100000957 no side effect Toxicity 0.000 abstract description 4
- 102000004196 processed proteins & peptides Human genes 0.000 abstract description 4
- 241000593508 Garcinia Species 0.000 abstract description 3
- 235000000885 Garcinia xanthochymus Nutrition 0.000 abstract description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 18
- 210000001789 adipocyte Anatomy 0.000 description 12
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 9
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 8
- 230000004130 lipolysis Effects 0.000 description 7
- 230000001965 increasing effect Effects 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- 230000037396 body weight Effects 0.000 description 5
- 230000000052 comparative effect Effects 0.000 description 5
- 235000019197 fats Nutrition 0.000 description 5
- 239000004615 ingredient Substances 0.000 description 5
- 230000002366 lipolytic effect Effects 0.000 description 5
- 235000016709 nutrition Nutrition 0.000 description 5
- 210000000579 abdominal fat Anatomy 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 229940089491 hydroxycitric acid Drugs 0.000 description 4
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 230000009467 reduction Effects 0.000 description 4
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 3
- 241000700159 Rattus Species 0.000 description 3
- 229920002472 Starch Polymers 0.000 description 3
- 235000019577 caloric intake Nutrition 0.000 description 3
- 235000005911 diet Nutrition 0.000 description 3
- 239000008101 lactose Substances 0.000 description 3
- 239000000845 maltitol Substances 0.000 description 3
- 235000010449 maltitol Nutrition 0.000 description 3
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 3
- 229940035436 maltitol Drugs 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 230000035764 nutrition Effects 0.000 description 3
- 239000008107 starch Substances 0.000 description 3
- 235000019698 starch Nutrition 0.000 description 3
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 3
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 2
- GUBGYTABKSRVRQ-PICCSMPSSA-N D-Maltose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 239000003613 bile acid Substances 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 229940098773 bovine serum albumin Drugs 0.000 description 2
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 238000005265 energy consumption Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- 235000019359 magnesium stearate Nutrition 0.000 description 2
- 235000013310 margarine Nutrition 0.000 description 2
- 239000003264 margarine Substances 0.000 description 2
- 235000012054 meals Nutrition 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 239000006188 syrup Substances 0.000 description 2
- 235000020357 syrup Nutrition 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- HSINOMROUCMIEA-FGVHQWLLSA-N (2s,4r)-4-[(3r,5s,6r,7r,8s,9s,10s,13r,14s,17r)-6-ethyl-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl]-2-methylpentanoic acid Chemical compound C([C@@]12C)C[C@@H](O)C[C@H]1[C@@H](CC)[C@@H](O)[C@@H]1[C@@H]2CC[C@]2(C)[C@@H]([C@H](C)C[C@H](C)C(O)=O)CC[C@H]21 HSINOMROUCMIEA-FGVHQWLLSA-N 0.000 description 1
- PZNPLUBHRSSFHT-RRHRGVEJSA-N 1-hexadecanoyl-2-octadecanoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCCCC(=O)O[C@@H](COP([O-])(=O)OCC[N+](C)(C)C)COC(=O)CCCCCCCCCCCCCCC PZNPLUBHRSSFHT-RRHRGVEJSA-N 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 102000029816 Collagenase Human genes 0.000 description 1
- 108060005980 Collagenase Proteins 0.000 description 1
- 206010009944 Colon cancer Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 206010033307 Overweight Diseases 0.000 description 1
- BELBBZDIHDAJOR-UHFFFAOYSA-N Phenolsulfonephthalein Chemical compound C1=CC(O)=CC=C1C1(C=2C=CC(O)=CC=2)C2=CC=CC=C2S(=O)(=O)O1 BELBBZDIHDAJOR-UHFFFAOYSA-N 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 108010073771 Soybean Proteins Proteins 0.000 description 1
- 238000000692 Student's t-test Methods 0.000 description 1
- 241000209140 Triticum Species 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 239000002830 appetite depressant Substances 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- 229960001948 caffeine Drugs 0.000 description 1
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 229960002424 collagenase Drugs 0.000 description 1
- 208000029742 colonic neoplasm Diseases 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 201000010063 epididymitis Diseases 0.000 description 1
- 235000020774 essential nutrients Nutrition 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 235000012631 food intake Nutrition 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 230000005802 health problem Effects 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000006371 metabolic abnormality Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 235000021590 normal diet Nutrition 0.000 description 1
- 235000019449 other food additives Nutrition 0.000 description 1
- 230000001991 pathophysiological effect Effects 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 229960003531 phenolsulfonphthalein Drugs 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000036186 satiety Effects 0.000 description 1
- 235000019627 satiety Nutrition 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 235000020183 skimmed milk Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 229940001941 soy protein Drugs 0.000 description 1
- 239000008347 soybean phospholipid Substances 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 210000002820 sympathetic nervous system Anatomy 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 238000012353 t test Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 238000004260 weight control Methods 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/20—Agglomerating; Granulating; Tabletting
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/30—Encapsulation of particles, e.g. foodstuff additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/50—Polysaccharides, gums
- A23V2250/51—Polysaccharide
- A23V2250/5114—Dextrins, maltodextrins
Abstract
Description
성 분 | 비교예 1 | 실시예 1 | 실시예 2 |
전분 | 50 | - | - |
식이섬유(난소화성 말토덱스트린) | - | 50 | 50 |
가르시니아 캄보지아 추출물 | - | - | 3.5 |
대두 펩타이드 | - | - | 1.3 |
녹차 데아닌 | - | - | 0.4 |
말티톨 | 39 | 39 | 33.8 |
락토오스 | 10 | 10 | 10 |
마그네슘 스테아레이트 | 1 | 1 | 1 |
대조군 | 가르시니아 캄보지아추출물 | 대두펩타이드 | 녹차데아닌 | |
유리된 글리세롤 양 (% of control) | 100 | 141±19 | 125±13 | 137±28 |
대조군 | 가르시니아 캄보지아 추출물 | 대두 펩타이드 | 녹차 데아닌 | 가르시니아 캄보지아추출물 +대두펩티이드 +녹차데아닌 | |
유리된 글리세롤 양 (% of control) | 100 | 241±32 | 197±17 | 298±22 | 462±37 |
비교예 1 (n=15명) | 실시예 1 (n=15명) | 실시예 2 (n=15명) | ||||
복용전 | 복용후 | 복용전 | 복용후 | 복용전 | 복용후 | |
체중(㎏) | 57.7±5.9 | 58.1±6.1 | 58.8±5.4 | 56.5±4.6* | 58.1±5.7 | 54.9±4.1* |
BMI | 24.4±1.5 | 24.1±2.1 | 24.3±2.9 | 23.1±1.5* | 24.9±1.8 | 23.0±1.8* |
체지방량(㎏) | 22.4±2.7 | 23.0±1.8 | 22.2±4.0 | 21.5±3.3 | 23.1±3.8 | 20.8±4.1* |
체지방율(%) | 33.8±3.0 | 34.0±3.1 | 34.5±2.4 | 32.3±3.5 | 33.7±2.4 | 29.4±3.6* |
WHR | 0.87±0.02 | 0.87±0.09 | 0.88±0.04 | 0.87±0.03 | 0.89±0.31 | 0.86±0.02* |
Claims (3)
- 난소화성 말토덱스트린 50 내지 60 중량%, 가르시니아 캄보지아 추출물 1 내지 10 중량%, 대두 펩타이드 1 내지 5 중량% 및 녹차 데아닌 0.1 내지 2 중량%를 함유하는 슬리밍 식품 조성물.
- 삭제
- 제 1항에 있어서 상기 조성물의 제형은 정제, 캡슐제, 과립제, 드링크제, 캬라멜, 또는 슬리밍 바임을 특징으로 하는 슬리밍 식품 조성물.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020030095414A KR100921172B1 (ko) | 2003-12-23 | 2003-12-23 | 식이섬유를 함유하는 슬리밍 식품 조성물 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020030095414A KR100921172B1 (ko) | 2003-12-23 | 2003-12-23 | 식이섬유를 함유하는 슬리밍 식품 조성물 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20050064127A KR20050064127A (ko) | 2005-06-29 |
KR100921172B1 true KR100921172B1 (ko) | 2009-10-13 |
Family
ID=37255763
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020030095414A KR100921172B1 (ko) | 2003-12-23 | 2003-12-23 | 식이섬유를 함유하는 슬리밍 식품 조성물 |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR100921172B1 (ko) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20100025299A (ko) * | 2008-08-27 | 2010-03-09 | 씨제이제일제당 (주) | 비만 또는 당뇨병의 예방 또는 개선용 조성물 |
KR101219779B1 (ko) * | 2009-12-04 | 2013-01-10 | 홍성창 | 체중 및 체지방 감소 효과가 있는 다이어트용 양갱 조성물 및 그 제조방법 |
KR101299436B1 (ko) * | 2010-05-06 | 2013-08-29 | 주식회사 쇼앤리 | 식욕억제용 조성물 및 그 조성물을 이용하여 제조된 식욕억제용 분말, 식용억제용 껌 및 식욕억제용 필름 |
EP3269251A1 (en) * | 2016-07-13 | 2018-01-17 | Roquette Frères | Short texture caramel |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100272487B1 (ko) * | 1992-03-27 | 2000-11-15 | 오쓰까 아끼히꼬 | 건강 음료 조성물 |
KR20030021215A (ko) * | 2003-02-12 | 2003-03-12 | 주식회사 아미노젠 | 천연 식이섬유와 기능성 천연 소재를 함유하는 항비만조성물 및 이를 유효성분으로 하는 다이어트 식품의 제조 |
KR20030084180A (ko) * | 2002-04-25 | 2003-11-01 | 한국식품개발연구원 | 비만억제 효과를 갖는 고추장 및 된장 |
KR100503208B1 (ko) | 2002-10-05 | 2005-07-21 | 주식회사 한국메디 | 다이어트 식품 조성물 |
-
2003
- 2003-12-23 KR KR1020030095414A patent/KR100921172B1/ko active IP Right Grant
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100272487B1 (ko) * | 1992-03-27 | 2000-11-15 | 오쓰까 아끼히꼬 | 건강 음료 조성물 |
KR20030084180A (ko) * | 2002-04-25 | 2003-11-01 | 한국식품개발연구원 | 비만억제 효과를 갖는 고추장 및 된장 |
KR100503208B1 (ko) | 2002-10-05 | 2005-07-21 | 주식회사 한국메디 | 다이어트 식품 조성물 |
KR20030021215A (ko) * | 2003-02-12 | 2003-03-12 | 주식회사 아미노젠 | 천연 식이섬유와 기능성 천연 소재를 함유하는 항비만조성물 및 이를 유효성분으로 하는 다이어트 식품의 제조 |
Also Published As
Publication number | Publication date |
---|---|
KR20050064127A (ko) | 2005-06-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20120052138A1 (en) | Composition comprising green tea extract | |
CN103238897A (zh) | 一种适用于糖尿病人的复合植物固体饮料 | |
CA2627314C (en) | Composition for treating obesity comprising extract from white kidney beans, red kidney beans, and green tea leaves | |
CN104381586A (zh) | 一种配比科学合理的大豆肽蛋白粉及其制备方法 | |
CN110447902B (zh) | 一种具有减肥功效的组合物 | |
KR20150051020A (ko) | 비만억제 및 다이어트 조성물 | |
KR100520408B1 (ko) | 비만개선용 조성물 | |
AU2016253140B2 (en) | Plant extracts for the treatment of excess weight and obesity | |
US20140127297A1 (en) | Nutraceutical composition for limiting the absorption of dietary lipids and for inducing weight loss, comprising, as active agent, at least one extract of carrot | |
KR20070113460A (ko) | 체중조절용 건강식품 조성물 | |
EP1656943A1 (en) | Extract from plant of japanese parsley family and process for producing the same | |
KR20200016608A (ko) | 체중조절용 건강식품 조성물 | |
KR20160141027A (ko) | 아위버섯 물 추출물을 유효성분으로 함유하는 대사성질환의 예방 및 치료용 약학적 조성물 또는 건강기능성식품 | |
KR100921172B1 (ko) | 식이섬유를 함유하는 슬리밍 식품 조성물 | |
KR20200063494A (ko) | 당뇨병 예방 또는 개선용 유황오리 엑기스의 제조방법 | |
KR20050094855A (ko) | 혈압 강하제 및 혈관 유연성 개선제 및 이들의 기능이부여된 식품 | |
KR100293890B1 (ko) | 동아녹즙및그잔사를사용하여제조된체중및혈당조절용식품조성물및그제조방법 | |
KR20170086198A (ko) | 발효 한약재와 식이섬유를 포함하는 다이어트 고형차 제조방법 및 이로부터 제조된 고형차 | |
KR20200130030A (ko) | 당뇨병 환자와 잠재환자의 혈당조절효과가 있는 요구르트 조성물 제조방법 | |
CN111165816A (zh) | 一种润肠通便的减肥代餐粉及其制备方法 | |
US20070092587A1 (en) | Extract from plant of japanese parsley family and process for producing the same | |
KR20050112942A (ko) | 비만 억제용 조성물 | |
KR101293032B1 (ko) | 다시마 및 부티르산 나트륨을 유효성분으로 함유하는 비만 치료 또는 예방용 약학조성물 | |
US20230027104A1 (en) | Nutritional powder comprising oligopeptides and applications thereof | |
KR101100904B1 (ko) | 세포내 지질 부착물 제거를 자극하는 비타민, 미네랄 및미량원소로 이루어진 새로운 상승작용성 조성물 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
N231 | Notification of change of applicant | ||
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20120918 Year of fee payment: 4 |
|
FPAY | Annual fee payment |
Payment date: 20130910 Year of fee payment: 5 |
|
FPAY | Annual fee payment |
Payment date: 20150914 Year of fee payment: 7 |
|
FPAY | Annual fee payment |
Payment date: 20170928 Year of fee payment: 9 |
|
FPAY | Annual fee payment |
Payment date: 20181001 Year of fee payment: 10 |
|
FPAY | Annual fee payment |
Payment date: 20190926 Year of fee payment: 11 |